A Single-arm Study to Evaluate Safety and Effectiveness of VX-548 for Acute Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

258

Participants

Timeline

Start Date

January 9, 2023

Primary Completion Date

December 12, 2023

Study Completion Date

December 12, 2023

Conditions
Pain
Interventions
DRUG

Suzetrigine

Tablets for oral administration.

Trial Locations (14)

33143

Mart Medical Research Group LLC, South Miami

33166

Mart Medical Research Group LLC, Miami

67226

Cypress Surgery Center, Wichita

68144

OrthoNebraska Hospital, Omaha

74037

Center for Orthopaedic Reconstruction and Excellence, Jenks

77380

Renovatio Clinical, Houston

78258

South Texas Spine & Surgical Hospital, San Antonio

78501

Futuro Clinical Trials, McAllen

84107

Wasatch Clinical Research, Salt Lake City

92801

Anaheim Clinical Trials, Anaheim

California

"Trovare Clinical Research , Bakersfield, CA"

Georgia

"Atlanta Center for Medical Research , Atlanta, GA"

Texas

"HD Research LLC , First Surgical Hospital"

"HD Research LLC , Legent Orthopedic Hospital"

All Listed Sponsors
lead

Vertex Pharmaceuticals Incorporated

INDUSTRY